Cancer is a leading cause of mortality, with 10 million deaths in 2020. As the number of people impacted by cancer is expected to increase, better-integrated cancer care is needed. This process also requires recording and monitoring to strengthen the appropriate care. Evidence suggests that Hospital-Based Cancer Registries (HBCRs) that collect administrative and routine clinical data could be important in providing integrated and equitable evidence based care. However, little is known about the role of HBCRs in delivering integrated cancer care that can potentially improve health outcomes, particularly in low-resource settings. This scoping review aims to understand better the current state and role of HBCRs in the delivery of integrated care, especially in low- and middle-income countries (LMICs). A systematic search was conducted in April 2020. Thirty articles were included. This review found that while HBCRs have been implemented in several countries, few studies evaluated the quality and effectiveness of registries, especially in LMICs. HBCRs in LMICs may function more as a data collection tool than an information system to influence clinical care decisions and monitoring, and are missing the opportunity to guide cancer care priorities and policies.